Toray Industries Inc (3402):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Toray Industries Inc (3402) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9986
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Toray Industries Inc (Toray) is a provider of advanced materials. The company’s product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides information processing services, functional film and machines; and materials for housing, construction and civil works. The company also provides analysis, physical evaluation, and research related services. Its products are used in apparel, industrial materials, automotive, construction, water treatment and medical industries. The company and its subsidiaries operate in various countries across Asia Pacific, North America, South America and Europe. Toray is headquartered in Tokyo, Japan.

Toray Industries Inc (3402) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Toray Industries Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Toray Industries Inc, Medical Devices Deals, 2012 to YTD 2018 9
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Toray Industries Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Hongkong Sansheng Medical Enters into Licensing Agreement with Toray Industries 11
Maruho Enters into Licensing Agreement with Toray Industries 12
Toray Industries Enters into Licensing Agreement with BONAC 13
Toray Industries Enters into Licensing Agreement with Orient Europharma 14
Toray Industries Enters into Licensing Agreement with Toray Medical 15
Toray Industries Enters Into Licensing Agreement With Fresenius Medical Care For TRK-820 16
Equity Offering 17
Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 17
Spectral Diagnostics Raises USD12 Million in First Tranche of Private Placement of Shares 19
Acquisition 21
Toray Industries Completes Acquisition Of 20% Stake In MicroBiopharm Japan From Mitsui 21
Toray Industries Inc – Key Competitors 22
Toray Industries Inc – Key Employees 23
Toray Industries Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Affiliate 27
Recent Developments 28
Other Significant Developments 28
May 11, 2017: Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Toray Industries Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Toray Industries Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Toray Industries Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Toray Industries Inc, Medical Devices Deals, 2012 to YTD 2018 9
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hongkong Sansheng Medical Enters into Licensing Agreement with Toray Industries 11
Maruho Enters into Licensing Agreement with Toray Industries 12
Toray Industries Enters into Licensing Agreement with BONAC 13
Toray Industries Enters into Licensing Agreement with Orient Europharma 14
Toray Industries Enters into Licensing Agreement with Toray Medical 15
Toray Industries Enters Into Licensing Agreement With Fresenius Medical Care For TRK-820 16
Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 17
Spectral Diagnostics Raises USD12 Million in First Tranche of Private Placement of Shares 19
Toray Industries Completes Acquisition Of 20% Stake In MicroBiopharm Japan From Mitsui 21
Toray Industries Inc, Key Competitors 22
Toray Industries Inc, Key Employees 23
Toray Industries Inc, Other Locations 24
Toray Industries Inc, Subsidiaries 25
Toray Industries Inc, Affiliate 27

List of Figures
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Toray Industries Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Toray Industries Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Toray Industries Inc (3402):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Hachijuni Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hachijuni Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hachijuni Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Consumers Energy Co (CMS PR B):電力:M&Aディール及び事業提携情報
    Summary Consumers Energy Co (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates elec …
  • Keyence Corp (6861):企業の財務・戦略的SWOT分析
    Keyence Corp (6861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ProQR Therapeutics NV (PRQR):製薬・医療:M&Aディール及び事業提携情報
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • GP Reinsurance EAD:企業の戦略的SWOT分析
    GP Reinsurance EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Saizeriya Co., Ltd.:企業の戦略・SWOT・財務分析
    Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Guangxi Investment Group Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Guangxi Investment Group Co Ltd (Guangxi Investment) is a diversified company. The company’s business segments include energy, aluminium, financial, cultural tourism, international business and medical and medical health business. Its energy business provides investments in the construction …
  • SynCore Biotechnology Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that new drug by research and development management and integration of technology resources. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05; and diagn …
  • Fcmb Group Plc:企業の戦略・SWOT・財務分析
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Seadrill Ltd (SDRL):企業の財務・戦略的SWOT分析
    Seadrill Ltd (SDRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Pioneer Natural Resources Co (PXD)-石油・ガス分野:企業M&A・提携分析
    Summary Pioneer Natural Resources Company (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activit …
  • Recordati SpA (REC):製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati SpA (Recordati), a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculo-skeletal disorders and …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務分析
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The National Commercial Bank:企業の戦略・SWOT・財務情報
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Al Taif Technical Services PJSC:企業の戦略・SWOT・財務分析
    Al Taif Technical Services PJSC - Strategy, SWOT and Corporate Finance Report Summary Al Taif Technical Services PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ex Scientia Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ex Scientia Ltd (Ex Scientia) is a biotechnology company that develops compounds with tailored polypharmacology. The company develops a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. It also develops molecular design technologies. EX …
  • Everspin Technologies Inc (MRAM):企業の財務・戦略的SWOT分析
    Everspin Technologies Inc (MRAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Michael Foods, Inc.:企業の戦略・SWOT・財務情報
    Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Brinker International, Inc.:企業の戦略・SWOT・財務分析
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kaiser Permanente:企業の戦略・SWOT・財務情報
    Kaiser Permanente - Strategy, SWOT and Corporate Finance Report Summary Kaiser Permanente - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆